Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion
Launched by FOUNDATION FOR ORTHOPAEDIC RESEARCH AND EDUCATION · Apr 3, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients 18 years or older,
- • Patients admitted to AHC for 1-3 level TLIF,
- • Patients who have given written informed consent,
- • BMI between 18-35 kg/m2,
- Exclusion Criteria:
- • Patients with known allergic reactions to standard of care analgesics,
- • Female patients who are pregnant
- • Patients with any previous lumbar spine instrumented surgery,
- • Chronic opioid use within 30 days prior to randomization that exceeds average ≥30 oral morphine equivalents/day,
- • Patients with known allergy to local anesthetics,
- • Patients with known or suspected to have neuromuscular disorders impairing neuromuscular blockade (e.g. myasthenia gravis).
About Foundation For Orthopaedic Research And Education
The Foundation for Orthopaedic Research and Education (FORE) is a dedicated nonprofit organization committed to advancing the field of orthopaedics through innovative research and education. By fostering collaboration among healthcare professionals, researchers, and industry partners, FORE aims to enhance patient care and improve clinical outcomes. The foundation supports a wide range of clinical trials and educational initiatives, focusing on cutting-edge treatments and technologies that address musculoskeletal disorders. Through its commitment to scientific excellence and community outreach, FORE strives to elevate the standards of orthopaedic practice and contribute to the overall advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Trial Officials
John Small, MD
Principal Investigator
Florida Orthopaedic Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported